Pharmaceutical Executive February 9, 2024
Mike Hollan

According to the study conducted by Technavio, North America will contribute to 37% of the expected growth.

The generic drug market is expected to show significant growth in the coming years.

At least, that’s according to a new study conducted by Technavio, a leading global technology research and advisory company.1 In a press release, the research company detailed the estimated growth, stating that it believes the market will grow by $176.25 billion by 2027. It also states that North America will contribute about 37% of this growth.

In the press release, a senior analyst at Technavio said, “The rising drug patent expirations are notably driving the generic drug market growth. Patent...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Survey / Study, Trends
How Medicare Says It Arrives At `Fair’ Prescription Drug Prices
Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline
Beyond Drugs: Blood-Based Therapies in Sickle Cell Disease and Beyond
A 24% reduction in pharmacy spend since 2021: MultiCare's story
How AI is streamlining cell and gene therapy manufacturing

Share This Article